PACB — Pacific Biosciences Of California Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Market Cap
$327.05m
Enterprise Value
$584.61m
Revenue
$154.01m

Annual balance sheet for Pacific Biosciences Of California, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	319	1,044	772	631	390
Net Total Accounts Receivable
Net Total Receivables	16.8	24.2	18.8	36.6	27.5
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	356	1,101	852	742	496
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	54.9	79.1	81.3	69	46.6
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	414	2,007	1,767	1,746	1,260
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	38.5	71.7	263	95	66.3
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	78.5	1,216	1,204	1,045	754
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	335	791	563	701	507
Total Liabilities & Shareholders' Equity	414	2,007	1,767	1,746	1,260
Total Common Shares Outstanding